The Venture Codex Logo

The Venture Codex

UPMC Enterprises

6425 Penn Ave Suite 200, Pittsburgh, PA, 15206, United States

Overview

Health care innovation and technology integration for impactful solutions.

Deals · 12mo

3

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

Consulting
Health Care
Information Technology

Investment portfolio

43rounds
NAMEDATESIZE
ai3Bio
Sep 2026Led
$48 MSeries A
BrainCheck
Feb 2026Participated
$13 MSeries A
Precede Biosciences
Jan 2026Participated
$84 MSeries B
Penguin Ai
Sep 2025Participated
$25 MSeries A
Ultromics
Jul 2025Participated
$55 MSeries C
Carta Healthcare
May 2025Led
$18 MSeries B
Latigo Biotherapeutics
Mar 2025Participated
$150 MSeries B
Percipio Health
Jan 2025Participated
$20 MSeries A
Ouro Medicines
Jan 2025Participated
$120 MSeries A
Noema Pharma
Dec 2024Participated
$162 MSeries B
Pip Care
Oct 2024Participated
$5 MSeries A
BrainCheck
Mar 2024Led
$15 MOther Equity
ai3Bio
Sep 2026Led
$48 MSeries A
BrainCheck
Feb 2026Participated
$13 MSeries A
Precede Biosciences
Jan 2026Participated
$84 MSeries B
Penguin Ai
Sep 2025Participated
$25 MSeries A
Ultromics
Jul 2025Participated
$55 MSeries C
Carta Healthcare
May 2025Led
$18 MSeries B
Latigo Biotherapeutics
Mar 2025Participated
$150 MSeries B
Percipio Health
Jan 2025Participated
$20 MSeries A
Ouro Medicines
Jan 2025Participated
$120 MSeries A
Noema Pharma
Dec 2024Participated
$162 MSeries B
Pip Care
Oct 2024Participated
$5 MSeries A
BrainCheck
Mar 2024Led
$15 MOther Equity
43
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

UPMC Enterprises: 43 funding rounds are recorded in the selected participation categories.All available history.
UPMC Enterprises: 43 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A211
Series B313
Series C+14
Other Equity43

Monthly Deal Activity

UPMC Enterprises: 43 deals are recorded across 125 months.All available history.
UPMC Enterprises: 43 deals are recorded across 125 months. All available history
MonthDeals
Jun '161
Jul '160
Aug '161
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '181
Apr '180
May '181
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '191
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '200
Sep '200
Oct '201
Nov '200
Dec '200
Jan '211
Feb '210
Mar '210
Apr '211
May '210
Jun '211
Jul '211
Aug '212
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '224
Jul '220
Aug '221
Sep '222
Oct '220
Nov '220
Dec '220
Jan '231
Feb '232
Mar '232
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '242
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '241
Jan '252
Feb '250
Mar '251
Apr '250
May '251
Jun '250
Jul '251
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '261
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

UPMC Enterprises: Health & Life Sciences is the largest displayed sector by deal count (42 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

UPMC Enterprises: Health & Life Sciences is the largest displayed sector by deal count (42 deals). All available history
SectorDeals
Health & Life Sciences42
AI & Machine Learning6
Space & Frontier Tech4
Professional Services3
Developer Tools3
Data, Analytics & IT2
Networks, Cloud & Communication1
Marketing & Advertising1
Enterprise Software1
Consumer & Lifestyle1

Deal Size Distribution

UPMC Enterprises: 43 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

UPMC Enterprises: 43 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M4
$10M-$25M13
$25M-$50M7
$50M-$100M11
$100M-$250M6
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

UPMC Enterprises: United States has the largest recorded deal count among the displayed regions (36 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

UPMC Enterprises: United States has the largest recorded deal count among the displayed regions (36 deals). All available history
RegionDeals
United States36
Europe5
Canada2
UPMC Enterprises: 20 co-investors are shown, with 4BIO Capital sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

UPMC Enterprises: 20 co-investors are shown, with 4BIO Capital sharing 4 recorded deals. All available history
Co-investorShared deals
4BIO Capital4
Alexandria Venture Investments4
Invus4
Jeito Capital4
Altitude Life Science Ventures3
BlueCross BlueShield Venture Partners3
Foresite Capital3
New Enterprise Associates3
Next Coast Ventures3
S3 Ventures3
Sofinnova Partners3
Takeda Ventures3
3M Ventures2
5AM Ventures2
Apollo2
Arkin Bio Ventures2
Bpifrance2
CureDuchenne Ventures2
DC Investment Partners2
Dementia Discovery Fund2

Investment Strategy

UPMC Enterprises: Led accounts for 28% and participating for 72% of round participation.All available history.
UPMC Enterprises: Led accounts for 28% and participating for 72% of round participation. All available history
CategoryDeals (count)Share (%)
Led1228%
Participating3172%
UPMC Enterprises: Single-lead accounts for 42% and co-led for 58% of lead dynamics.All available history.
UPMC Enterprises: Single-lead accounts for 42% and co-led for 58% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead542%
Co-led758%

Team

Adele Towers

Director, Risk Adjustment

Brad Ryan

Executive In Residence

Brian Susko

Vice President, Engineering & Product Development

David Gibson

Chief Financial Officer

Fabian Tenenbaum

Chief Executive Officer​

Hank Safferstein

Executive In Residence

Mary Beth Navarra-Sirio

Vice President of Product Management and Market Development

Matt Grant
Matthias Kleinz

Member Board of Directors

Nancy Zimmerman

Executive In Residence

Steve Whitehurst

Operating Partner/EIRO